Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy.
Molecular medicine reports 2013 Feb 7 (2): 2.
Mirakhorli M, Rahman SA, Abdullah S, Vakili M, Rozafzon R, Khoshzaban A
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy.
Cancer chemotherapy and pharmacology 2012 May 69 (5): 1221-7.
Kim Kyu-pyo, Ahn Jin-Hee, Kim Sung-Bae, Jung Kyung Hae, Yoon Dok Hyun, Lee Jung Shin, Ahn Sei-Hy